Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPIPA7 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | RPS6KA1 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
mRNA | PPFIA4 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-09 |
mRNA | TIFAB | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-09 |
mRNA | ZNF230 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | TMEM74 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-09 |